Weiskirchen R, Tacke F (2016) Liver fibrosis: from pathogenesis to novel therapies. Dig Dis 34:410–422

Article  PubMed  Google Scholar 

Gines P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS (2021) Liver cirrhosis. Lancet 398:1359–1376

Article  PubMed  Google Scholar 

Tsochatzis EA, Bosch J, Burroughs AK (2012) New therapeutic paradigm for patients with cirrhosis. Hepatology 56:1983–1992

Article  CAS  PubMed  Google Scholar 

Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, Arrese M, Fracanzani AL, Ben Bashat D, Lackner K et al (2021) Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med 27:1825–1835

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ratziu V, Sanyal A, Harrison SA, Wong VW, Francque S, Goodman Z, Aithal GP, Kowdley KV, Seyedkazemi S, Fischer L et al (2020) Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study. Hepatology 72:892–905

Article  CAS  PubMed  Google Scholar 

Harrison SA, Abdelmalek MF, Caldwell S, Shiffman ML, Diehl AM, Ghalib R, Lawitz EJ, Rockey DC, Schall RA, Jia C et al (2018) Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis. Gastroenterology 155:1140–1153

Article  CAS  PubMed  Google Scholar 

Fallowfield JA, Jimenez-Ramos M, Robertson A (2021) Emerging synthetic drugs for the treatment of liver cirrhosis. Expert Opin Emerg Drugs 26:149–163

Article  CAS  PubMed  Google Scholar 

Hammond GL (2016) Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol 230:R13-25

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laurent MR, Hammond GL, Blokland M, Jardi F, Antonio L, Dubois V, Khalil R, Sterk SS, Gielen E, Decallonne B et al (2016) Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep 6:35539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee SR, Kim NR, Mukae M, Won YS, Hong EJ (2025) Sex hormone-binding globulin dampens growth and metastasis of breast cancer in an estrogen-independent manner. Am J Physiol Cell Physiol 328:C1685–C1698

Article  PubMed  Google Scholar 

Lee SR, Lee YH, Yang H, Lee HW, Lee GS, An BS, Jeung EB, Park BK, Hong EJ (2019) Sex hormone-binding globulin suppresses NAFLD-triggered hepatocarcinogenesis after menopause. Carcinogenesis 40:1031–1041

Article  CAS  PubMed  Google Scholar 

Saez-Lopez C, Villena JA, Simo R, Selva DM (2020) Sex hormone-binding globulin overexpression protects against high-fat diet-induced obesity in transgenic male mice. J Nutr Biochem 85:108480

Article  CAS  PubMed  Google Scholar 

Saez-Lopez C, Salcedo-Allende MT, Hernandez C, Simo-Servat O, Simo R, Selva DM (2019) Sex hormone-binding globulin expression correlates with acetyl-coenzyme A carboxylase and triglyceride content in human liver. J Clin Endocrinol Metab 104:1500–1507

Article  PubMed  Google Scholar 

Lee SR, Hong E-J (2021) Sex hormone-binding globulin impedes hepatocellular carcinoma growth via MERTK regulation. Genes & Diseases. https://doi.org/10.1016/j.gendis.2021.10.003

Article  Google Scholar 

van der Meer JH, van der Poll T, van’t Veer C (2014) TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood 123:2460–2469

Article  PubMed  Google Scholar 

Shi N, Wang Z, Zhu H, Liu W, Zhao M, Jiang X, Zhao J, Ren C, Zhang Y, Luo L (2022) Research progress on drugs targeting the TGF-beta signaling pathway in fibrotic diseases. Immunol Res 70:276–288

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luangmonkong T, Suriguga S, Bigaeva E, Boersema M, Oosterhuis D, de Jong KP, Schuppan D, Mutsaers HAM, Olinga P (2017) Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. Br J Pharmacol 174:3107–3117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Li R, Liu Q, Zhou J, Huang H, Huang Y, Zhang Z, Wu T, Tang Q, Huang C et al (2020) SB431542-loaded liposomes alleviate liver fibrosis by suppressing TGF-beta signaling. Mol Pharm 17:4152–4162

Article  CAS  PubMed  Google Scholar 

Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, Liu X, Zhang R, Wang Y (2019) Praziquantel ameliorates CCl4 -induced liver fibrosis in mice by inhibiting TGF-beta/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol 176:4666–4680

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Wang Y, Ma M, Jiang S, Zhang X, Zhang Y, Yang X, Xu C, Tian G, Li Q et al (2019) Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-beta signaling. EBioMedicine 40:43–55

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsieh YC, Lee KC, Lei HJ, Lan KH, Huo TI, Lin YT, Chan CC, Schnabl B, Huang YH, Hou MC et al (2021) (Pro)renin receptor knockdown attenuates liver fibrosis through inactivation of ERK/TGF-beta1/SMAD3 pathway. Cell Mol Gastroenterol Hepatol 12:813–838

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reichl P, Dengler M, van Zijl F, Huber H, Fuhrlinger G, Reichel C, Sieghart W, Peck-Radosavljevic M, Grubinger M, Mikulits W (2015) Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma. Hepatology 61:930–941

Article  CAS  PubMed  Google Scholar 

Landolt L, Furriol J, Babickova J, Ahmed L, Eikrem O, Skogstrand T, Scherer A, Suliman S, Leh S, Lorens JB et al (2019) AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction. Physiol Rep 7:e14091

Article  PubMed  PubMed Central  Google Scholar 

Tutusaus A, de Gregorio E, Cucarull B, Cristobal H, Areste C, Graupera I, Coll M, Colell A, Gausdal G, Lorens JB et al (2020) A functional role of GAS6/TAM in nonalcoholic steatohepatitis progression implicates AXL as therapeutic target. Cell Mol Gastroenterol Hepatol 9:349–368

Article  PubMed  Google Scholar 

Barcena C, Stefanovic M, Tutusaus A, Joannas L, Menendez A, Garcia-Ruiz C, Sancho-Bru P, Mari M, Caballeria J, Rothlin CV et al (2015) Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol 63:670–678

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janne M, Hogeveen KN, Deol HK, Hammond GL (1999) Expression and regulation of human sex hormone-binding globulin transgenes in mice during development. Endocrinology 140:4166–4174

Article  CAS  PubMed  Google Scholar 

Janne M, Deol HK, Power SG, Yee SP, Hammond GL (1998) Human sex hormone-binding globulin gene expression in transgenic mice. Mol Endocrinol 12:123–136

Article  CAS  PubMed  Google Scholar 

Martin-Mateos R, De Assuncao TM, Arab JP, Jalan-Sakrikar N, Yaqoob U, Greuter T, Verma VK, Mathison AJ, Cao S, Lomberk G et al (2019) Enhancer of zeste homologue 2 inhibition attenuates TGF-beta dependent hepatic stellate cell activation and liver fibrosis. Cell Mol Gastroenterol Hepatol 7:197–209

Article  PubMed  Google Scholar 

Huang F, Chen YG (2012) Regulation of TGF-beta receptor activity. Cell Biosci 2:9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colak S, Ten Dijke P (2017) Targeting TGF-beta signaling in cancer. Trends in cancer 3:56–71

Article